GDRX - CIK 0001809519
GoodRx Holdings, Inc. trades as GDRX and has a market capitalization of $1.01 B, making it the #2632 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $796.85M, up 0.6% from the prior year and net income of $30.40M. This page tracks GoodRx Holdings, Inc. through 547 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 7 fiscal years GoodRx Holdings, Inc.'s revenue grew from $249.52M to $796.85M, a compound annual growth rate of 18.0%. Net profit margin compressed from 17.6% to 3.8% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider sale notice | 144 | 2026-05-13 |
| Insider trade | 4 | 2026-05-12 |
| Quarterly report | 10-Q | 2026-05-06 |
| Major company event | 8-K | 2026-05-06 |
| New insider ownership | 3 | 2026-05-01 |
| Annual report to shareholders | ARS | 2026-04-29 |
GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs - GoodRx
GoodRx Reports First Quarter 2026 Results - GoodRx
GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients - GoodRx
GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call - GoodRx
GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price - GoodRx
The largest companies sharing GoodRx Holdings, Inc.'s SEC industry classification (services-computer processing & data preparation).
GoodRx Holdings, Inc. (GDRX) has a market capitalization of $1.01 B as of 2026-05-29, ranking #2632 among US-listed companies.
GoodRx Holdings, Inc. reported revenue of $796.85M for fiscal year 2025, an increase of 0.6% year over year.
Yes. GoodRx Holdings, Inc. reported net income of $30.40M in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.